Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

Clinical Experience of Medtronic-Hall Valve

Medtronic-Hall 기계판막의 임상경험

  • 김종원 (부산대학교 의과대학 흉부외과학 교실) ;
  • 정성운 (부산대학교 의과대학 흉부외과학 교실)
  • Published : 1998.11.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Medtronic-Hall mechanical valve is a world widely using prosthesis. But, in Korea, the clinical result from Medtronic-Hall valve replacement is not frequenthy available. Materials and methods: From March 1986 to May 1990, 50 patients underwent valve replacement surgery with Medtronic-Hall valve at Pusan National University Hospital. Seventeen were male and thirty three were female and ra nging in age from 16 to 70 years of age(mean=35 years). Results: The causes of valvular lesion were rheumatic in 43 patients, bicuspid aortic valve in 3 patients, degenerative lesion in three patients and bacterial endocarditis in one patient. The operative procedures were mitral valve replacement(MVR) in 38, aortic valve replacement(AVR) in 5 and double valve replacement(DVR) in 7. The most commonly used valve size was 21mm in AVR, 29mm in MVR. Concomitant surgical procedures were performed in 15 patients; left atrial thrombectomy in 9, left atrial auricle obliteration in 6 and tricuspid annuloplasty in 5(Kay: 2, DeVega: 3). New York Heart Association functional class was mostly Class Ⅲ or Ⅳ(91.5%) preoperatively and ClassⅠor Ⅱ(87.2%) after operation. The findings of postoperative echocardiogram of LAD, LVESD, LVEDD were reduced compared with preoperative period and ejection fraction was increased compared with preoperative period. Postoperative complications were massive bleeding in three, low cardiac output syndrome in two, thromboembolism in one and fulminant hepatitis in one patient. There were three hospital deaths and their causes were low cardiac output syndrome in two and rupture of left ventricle in one patient. The 5 year survival rate was 93.65±0.71% and 10 year actuarial survival rate was 88.27±6.42%. Conclusions: Medtronic-Hall mechanical valve has low valve related complication rate. It's durability and hemodynamic performance is comparable to other mechanical valves.

연구배경 : Medtronic-Hall 기계판막은 세계적으로 흔히 쓰이고 있으나, 우리 나라에는 그에 대한 임상연구가 되어 있지 않다 재료 및 방법 : 1986년 3월부터 1990년 5월까지 Medtronic-Hall 기계판막을 이용한 인공 심장판막 치환 환자 50례를 대상으로 하였다. 환자의 평균 연령은 35세였고 남녀비는 17:33이었다. 결과 : 판막 병변의 원인은 류마티스성이 43례로 대부분을 차지했고 38명의 환자에서 승모판 치환술을 7명에서 중복판막치환술을 그리고 5명의 환자에서 대동맥판막 치환술을 시행하였다. 술전 NYHA 기능 분류는 Class III 혹은 Class IV가 91.5%였지만 술후는 ClassI혹은 Class II가 87.2%로 호전된 양상을 보였다. 심장초음파 검사상 좌심방내경, 수축말기 및 확장말기 좌심실내경은 술후 모두 감소하였고 심박출률은 증가하였다. 술후 합병증은 출혈 3례, 저심박출 증후군 2례, 혈전색전증 1례, 전격성 간염 1례가 있었고 병원 사망례는 3례였다. 혈전색전증의 발생률은 1.5%/환자.년이었고 5년 생존률은 93.65$\pm$0.71%, 10년 생존률은 88.27$\pm$6.4%였다. 결론 : 이상에서 Medtronic-Hall 기계판막은 판막에 관련된 합병증 발생률이 낮고 판막의 내구성도 뛰어나며 혈역학적 수행능력이 타 기계판막에 뒤떨어지지 않는 판막으로 확인되었다.

Keywords

References

  1. Ann Thorac Surg v.52 Mechanical Cardiac Valvular Prostheses Akins CW
  2. Glenn's Thorac and Cardiovasc Surg(5th Ed.) Selection and complications of cardiac valvular prostheses Whittlesey D;Geha AS;Arthur EB;Alexander SG;Graeme LH;Hiller L;Keith SN
  3. Am J Cariol v.35 Long-term follow-up of isolated replacement of the aortic or mitral valve with Starr-Edwards prosthesis Barnhorst DA;Oxman HA;Connolly DC;McGoon DC
  4. J Thorac Cardiovase Surg v.85 Ten to fifteen year reassessment of the performance characteristics of the Starr-Edwards Model 6120 mitral valve prosthesis Miller DC;Reitz BA;Shumway NE
  5. J Thorac Cardiovase Surg v.88 Performance characteristics of the Starr-Edwards Model 1260 aortic valve prosthesis beyond 10 years Miller DC;Oyer PE;Mitchell RS;Shumway NE
  6. Surg Forum v.30 Clinical and hemodynamic results with the St. Jude Medical arotic valve prosthesis Emery RW;Anderson RW;Nicoloff DM
  7. Am J Cardol v.45 St. Jude aortic valve prosthesis postoperative hemodynamic evaluation at rest and excercise Hoback J;Wahn Y;Lindsay WG
  8. Ann Thorac Surg v.44 Thrombotic and bleeding complications of prosthetic heart valves Edmunds LH Jr
  9. J Thorac Cardiovasc Surg v.100 Ten year experience with the St. Jude Medical valve for primary valve replacement Czer LS;Chaux A;Matloff JM(et al.)
  10. 대흉외지 v.26 Carbomedics 기계판막의 임상경험 김기출;채헌;안혁;김용진;김종환;노준량
  11. Am Heart J v.114 The St. Jude valve: analysis of thromboembolism, warfarin related and survival Czer LS;Matloff JM;Chaux A(et al.)
  12. Ann Thorac Surg v.47 Ten years' experience with the St. Jude Medical prosthesis Arom KV;Nicoloff DM;Kersten TE;Northrup WF Ⅲ;Lindsay WG;Emery RW
  13. Ann Thorac Surg v.56 St. Jude prosthesis for aortic and mitral valve replacement : A ten-year experience Kratz JM;Crawford FA Jr;Sade RM;Crumbley AV;Stroud MR
  14. Ann Thorac Surg v.57 Twelve years' experience with the St. Jude Medical valve proshtesis Nakano K;Koyanagi H;Hashimoto A(et al.)
  15. Ann Thorac Surg v.46 Rupture of left vantricle following mitral valve replacement Karlson KJ;Ashiraf MM;Berger RL
  16. Ann Thorac Surg v.46 Rupture of the posterior wall of the left ventricle after mitral valve replacement : etiology and technical considerations Azariades M;Lennox SC
  17. Cor Europaeum v.3 no.3 The Medtronic-Hall Prosthetic Heart Valve-Ten Years' Experience Zhu X;Wang Y;Wu X
  18. Am J Cardiol v.49 Evaluation of ventricular function using two dimensional echocardiography Henry WL
  19. Circulation v.43 Evaluation of left ventricular fuction by echocardiography Fortein NJ;Hood WP;Carge E